Phase 1 Allergies Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy

Peanut Allergies

Mabylon AG48 enrolled1 locationNCT07287033

Not Yet Recruiting

Phase 1

A Bioequivalence study of loratadine 5mg Chewable Tablets of AFT Pharmaceuticals compared with Children's Claratyne® Grape 5mg Chewable Tablets in healthy human adults under fasting conditions.

Allergies

AFT Pharmaceuticals Ltd56 enrolled1 locationACTRN12624000019505

Completed

Phase 1

An interventional study to evaluate the effect and safety of PRN473 topical on skin reactions of otherwise healthy participants with allergies to common allergens.

Immunoglobulin E-Mediated Allergies

Principia Biopharma Inc.24 enrolled1 locationACTRN12620000693921